Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SFDA Sticks To Familiar Theme During Second Press Conference: Food And Drug Safety Dominates Discussion

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State Food and Drug Administration stuck to a familiar theme during its second monthly press conference in Beijing Aug. 8, outlining several measures intended to improve food and drug safety
Advertisement

Related Content

China's SFDA Launches Inspection Campaign To Ferret Out Fake Drugs Sold In Retail Outlets
China's SFDA Launches Inspection Campaign To Ferret Out Fake Drugs Sold In Retail Outlets
China Issues Regulation To Restrict Access To Medical Health Web Sites
China Issues Regulation To Restrict Access To Medical Health Web Sites
China Will Block 74 Websites Operated By Companies Illegally Selling Traditional Chinese Medicines Online
China Will Block 74 Websites Operated By Companies Illegally Selling Traditional Chinese Medicines Online
China Beefs Up Regs For Drugs Containing Codeine, Online Distributors: SFDA Press Conference
China Beefs Up Regs For Drugs Containing Codeine, Online Distributors: SFDA Press Conference
Advertisement
UsernamePublicRestriction

Register

SC066453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel